Edward Abraham

51.3k citations

337 papers · 38.0k indexed · 12 hit papers · h-index 88

Critical Care and Intensive Care Medicine top 0.02%
Clinical Biochemistry top 0.01%
- Advanced Glycation End Products research 24
Immunology top 0.05%
- Immune Response and Inflammation 110
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 37
- Immune cells in cancer 18
Epidemiology top 0.05%
- Sepsis Diagnosis and Treatment 84
Nephrology top 0.2%
Pulmonary and Respiratory Medicine
- Respiratory Support and Mechanisms 56
- Neonatal Respiratory Health Research 24
Cancer Research
- NF-κB Signaling Pathways 37

Co-authors: Steven M. Opal Jean‐Louis Vincent Gang Liu Jonathan Cohen John C. Marshall Mitchell M. Levy Derek C. Angus Mitchell P. Fink
Cited by: Critical Care and Intensive Care Medicine Clinical Biochemistry Immunology
Journals: Critical Care Medicine (56 papers)The Journal of Immunology (30 papers)American Journal of Respiratory and Critical Care Medicine (21 papers)
Partner nations: United States France South Korea

In The Last Decade

Edward Abraham

335 papers receiving 37.2k citations

Hit Papers

12 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2018 Nature Medicine
2010 The Journal of Experimental Medicine
2005 American Journal of Physiology-Cell Physiology
2005 New England Journal of Medicine
2004 Journal of Biological Chemistry
2003 Critical Care Medicine
2003 Critical Care Medicine
2003 Intensive Care Medicine
2000 The Journal of Immunology
1999 Science
1996 New England Journal of Medicine
1995 JAMA

Peers

Countries citing papers authored by Edward Abraham

Since Specialization

Citations

This map shows the geographic impact of Edward Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Abraham more than expected).

Fields of papers citing papers by Edward Abraham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Abraham. The network helps show where Edward Abraham may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Edward Abraham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward Abraham Line = papers co-authored together Edward Abraham links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of Liposomal Vitamin C Stabilized by Gum Arabic Nanospheres Using Metazome Technology: Characterization, In Vitro Release, and Oral Bioavailability of Vitamin C in a Randomized, Double-Blind, Single-Dose, Two-Period, Two-Way Crossover Study Augustine Amalraj,Edward Abraham,Kim Hyun-Yong,Sreeraj Gopi	2025	0
2	Cholesterol-25-hydroxylase promotes efferocytosis and resolution of lung inflammation JCI Insight ·Jennifer H. Madenspacher,Eric D. Morrell,Kymberly M. Gowdy,Jeffrey G. McDonald,Bonne M. Thompson,Ginger W. Muse,Jennifer Martinez,Seddon Y. Thomas,Carmen Mikacenic,Jerry A. Nick,Edward Abraham,Stavros Garantziotis,Renee D. Stapleton,Encarnación Cereijo,Mary Jane Thomassen,William J. Janssen,Donald N. Cook,Mark M. Wurfel,Michael B. Fessler	2020	55
3	PAI-1 inhibits neutrophil efferocytosis Proceedings of the National Academy of Sciences ·Young‐Jun Park,Gang Liu,Emmanuel Lorne,Xia Zhao,Jing Wang,Yuko Tsuruta,Jaroslaw W. Zmijewski,Edward Abraham	2008	98
4	Drotrecogin alfa (activated) in severe sepsis - Reply New England Journal of Medicine ·Edward Abraham,Pierre‐François Laterre	2006	3
5	Interstitial Lung Disease, Lung Cancer, Lung Transplantation, Pulmonary Vascular Disorders, and Sleep-disordered Breathing in AJRCCM in 2004 American Journal of Respiratory and Critical Care Medicine ·T. Douglas Bradley,York E. Miller,Fernando J. Martínez,Derek C. Angus,William MacNee,Edward Abraham	2005	1
6	Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004 American Journal of Respiratory and Critical Care Medicine ·Leonardo M. Fabbri,Stephen P. Peters,Ian Pavord,Sally E. Wenzel,Stephen C. Lazarus,William MacNee,François Lemaire,Edward Abraham	2005	11
7	Critical Care in AJRCCM 2004 American Journal of Respiratory and Critical Care Medicine ·Derek C. Angus,Akitoshi Ishizaka,Michael A. Matthay,François Lemaire,William MacNee,Edward Abraham	2005	4
8	Outcome measures for clinical research in sepsis: A report of the 2nd Cambridge Colloquium of the International Sepsis Forum Critical Care Medicine ·John C. Marshall,Jean‐Louis Vincent,Gordon Guyatt,Derek C. Angus,Edward Abraham,Gordon R. Bernard,Claire Bombardier,Thierry Calandra,Henrik Jørgensen,Richard Sylvester,Maarten Boers	2005	110
9	Transfusion-related acute lung injury: Definition and review Critical Care Medicine ·Pearl Toy,Mark A. Popovsky,Edward Abraham,Daniel R. Ambruso,Leslie G. Holness,Patricia Kopko,Janice G. McFarland,Avery B. Nathens,Christopher C. Silliman,David F. Stroncek	2005	467
10	Cystic Fibrosis, Pediatrics, Control of Breathing, Pulmonary Physiology and Anatomy, and Surfactant Biology in AJRCCM in 2004 American Journal of Respiratory and Critical Care Medicine ·Andrew Bush,Frank J. Accurso,William MacNee,Stephen C. Lazarus,Edward Abraham	2005	1
11	Activated Protein C Inhibits Local Coagulation after Intrapulmonary Delivery of Endotoxin in Humans American Journal of Respiratory and Critical Care Medicine ·Tom van der Poll,Marcel Levi,Jerry A. Nick,Edward Abraham	2005	78
12	Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial* Critical Care Medicine ·Steven M. Opal,Pierre‐François Laterre,Edward Abraham,Bruno François,Xavier Wittebole,S. C. Lowry,Jean-François Dhainaut,Brian Warren,Thierry Dugernier,Ángel Crespo López,Miguel Sánchez,Ignace Demeyer,Luis Jáuregui,José A. Lorente,William T. McGee,Konrad Reinhart,Safa’a Mohammad Khalil,Sonia Souza,John P. Pribble	2004	103
13	Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure Critical Care Medicine ·Edward Abraham,Ministerium für Verkehr Mecklenburg-Vorpommern,Venkata Bandi,J-S. Liu,Stephen F. Lowry,Richard G. Wunderink,Roland M.H. Schein,William L. Macias,Simona Skerjanec,Alex Dmitrienko,Nagy A. Farid,S. Thomas Forgue,R. Schlickeiser	2003	82
14	2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conferencebreakdown → Critical Care Medicine ·Mitchell M. Levy,Mitchell P. Fink,John C. Marshall,Edward Abraham,Derek C. Angus,(unknown),Jonathan Cohen,Steven M. Opal,Jean‐Louis Vincent,Graham Ramsay	2003	4516
15	Early Alterations in Neutrophil Activation Are Associated with Outcome in Acute Lung Injury American Journal of Respiratory and Critical Care Medicine ·Kuang‐Yao Yang,John J. Arcaroli,Edward Abraham	2003	104
16	Management of the agitated intensive care unit patient Critical Care Medicine ·Ian L. Cohen,T. James Gallagher,Anne S. Pohlman,Joseph F. Dasta,Edward Abraham,Fahri Azhari	2002	63
17	Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study Critical Care Medicine ·Edward Abraham,Konrad Reinhart,Petr Svoboda,Allan Seibert,D Olthoff,Anthony Dal Nogare,Russell G. Postier,G. Hempelmann,Thomas Butler,Eike Martin,Christian Zwingelstein,Sandra Percell,Vincent Shu,Anton Leighton,Abla A. Creasey	2001	193
18	Extracellular Superoxide Dismutase Attenuates Lung Injury after Hemorrhage American Journal of Respiratory and Critical Care Medicine ·Russell P. Bowler,John J. Arcaroli,Dilmurov Khaydaralievich Kuronov,Felix Orlando Dickinson,Jan W. Slot,Edward Abraham	2001	54
19	Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation Critical Care Medicine ·Edward Abraham,Michael A. Matthay,Charles A. Dinarello,Jean‐Louis Vincent,Jonathan Cohen,Steven M. Opal,M. P. Glauser,Polly E. Parsons,Charles J. Fisher,John E. Repine	2000	263
20	Impact of Immunomodulating Therapy on Morbidity in Patients with Severe Sepsis American Journal of Respiratory and Critical Care Medicine ·Didier Pittet,Stephan Harbarth,Peter M. Suter,Konrad Reinhart,Anton Leighton,Christopher M. Barker,吴文健,Edward Abraham	1999	30

About Edward Abraham

Edward Abraham is a scholar working on Critical Care and Intensive Care Medicine, Immunology and Cancer Research, having authored 337 papers that have together received 38.0k indexed citations. Recurring topics across this work include Immune Response and Inflammation (110 papers), Sepsis Diagnosis and Treatment (84 papers), Respiratory Support and Mechanisms (56 papers), NF-κB Signaling Pathways (37 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (37 papers), Neonatal Respiratory Health Research (24 papers), Advanced Glycation End Products research (24 papers) and Immune cells in cancer (18 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (4.7k citations), Clinical Biochemistry (5.3k citations) and Immunology (12.5k citations). Edward Abraham has collaborated with scholars based in United States, France and South Korea. Frequent co-authors include Steven M. Opal, Jean‐Louis Vincent, Gang Liu, Jonathan Cohen, John C. Marshall, Mitchell M. Levy, Derek C. Angus, Mitchell P. Fink, Graham Ramsay and Robert Shenkar. Their work appears in journals such as Critical Care Medicine, The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine, American Journal of Physiology-Lung Cellular and Molecular Physiology and Intensive Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact